About ATH
A clinical-stage biotechnology company developing treatments for neurodegenerative conditions including Parkinson's disease, Alzheimer's disease, and Huntington's disease.
All News for ATH
No news articles found for ATH yet.
ATH
ASX
Health Care Sector News